Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Validation of the Stockholm3 Test on Men on Active Surveillance: the CHAS3-Trial

NCT07478536 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT07478536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07478536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Validation of the Stockholm3 Test on Men on Active Surveillance: the CHAS3-Trial
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2026
Completion date
August 31, 2028
Enrollment
350 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

active surveillance for prostate cancer, prostate cancer